Please assess the completion status of the following clinical trial:

Trial Title: Daptomycin Versus Placebo in Patients With Neutropenia and Fever

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients in the above categories who are currently undergoing chemotherapy.~2. Patients at least 18 of age.~3. Patient expected to reach an absolute granulocyte count of \<100 cells/mm3~4. Patients who have given written consent because of the above criteria must have at least one temperature of greater or equal to 38.3° or temperatures \> 38o on at least two occasions before study drug is administered.~Exclusion Criteria:~1. Patients with lymphoma or with solid tumor undergoing initial chemotherapy. Their neutropenia is of insufficient duration for adequate test of the value of an anti-gram positive antibiotic.~2. Patients undergoing auto-transplantation, for the same reason as above.~3. Patients with evidence of a clinical infection such as presence of a pulmonary infiltrate by x-ray or clinical evidence for the presence of cellulitis.~4. Patients who have received daptomycin in the two weeks prior to enrollment.~5. Patients with concomitant use of vancomycin.~6. Patients with creatinine clearance \< 30 ml/min or CPK \> 3x normal~7. Patients with significant hepatic dysfunction, defined as baseline liver function tests \> 5x above normal.~8. Patients with known allergy to daptomycin.~9. Patients previously in this study.~10. Women of child bearing age who are either lactating or pregnant (as evidenced by a positive urine pregnancy test or positive serum beta-HCG).~11. Patients previously enrolled in this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Daptomycin (Type: ACTIVE_COMPARATOR): Daptomycin intravenous 8mg/kg once per day 5-10 days.
- Saline Placebo (Type: PLACEBO_COMPARATOR): Saline solution

Based on this trial design, predict the completion outcome and termination type (if applicable).